Skip to main content
SpringerLink
Log in

Cross-Sectional Imaging Techniques: The Use of Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) in the Management of Germ Cell Tumors

  • Chapter
Imaging in Oncological Urology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Horwich A. In: Horwich A, editor. Testicular cancer – investigation and management: Chapman and Hall Medical; 1996. pp. 1–17.

    Google Scholar 

  2. Loughrey GJ, Carrington BM, Anderson H, Dobson MJ, Lo Ying Ping F. The value of specialist oncological radiology review of cross-sectional imaging. Clin Radiol. 1999;54(3):149–54; discussion 54–5.

    Article  PubMed  CAS  Google Scholar 

  3. Lawton AJ, Mead GM. Staging and prognostic factors in testicular cancer. Semin Surg Oncol. 1999;17(4):223–9.

    Article  PubMed  CAS  Google Scholar 

  4. Barentsz J, Takahashi S, Oyen W, et al. Commonly used imaging techniques for diagnosis and staging. J Clin Oncol. 2006;24(20):3234–44.

    Article  PubMed  CAS  Google Scholar 

  5. Schnall M, Rosen M. Primer on imaging technologies for cancer. J Clin Oncol. 2006;24(20):3225–33.

    Article  PubMed  CAS  Google Scholar 

  6. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology. 2001;218(1):27–38.

    PubMed  CAS  Google Scholar 

  7. Hricak H, Hamm B, Bohyun K. Imaging of the scrotum: Raven Press; 1995.

    Google Scholar 

  8. Noone T, Huch-Böni R, Semelka RC. MRI of the abdomen and pelvis. New York: Wiley-Liss; 1997. pp. 541–69.

    Google Scholar 

  9. Cramer BM, Schlegel EA, Thueroff JW. MR imaging in the differential diagnosis of scrotal and testicular disease. Radiographics. 1991;11(1):9–21.

    PubMed  CAS  Google Scholar 

  10. Kubik-Huch RA, Hailemariam S, Hamm B. CT and MRI of the male genital tract: radiologic-pathologic correlation. Eur Radiol. 1999;9(1):16–28.

    Article  PubMed  CAS  Google Scholar 

  11. Woodward PJ, Sohaey R, O’Donoghue MJ, Green DE. From the archives of the AFIP: tumors and tumorlike lesions of the testis: radiologic-pathologic correlation. Radiographics. 2002;22(1):189–216.

    PubMed  Google Scholar 

  12. Johnson JO, Mattrey RF, Phillipson J. Differentiation of seminomatous from nonseminomatous testicular tumors with MR imaging. AJR Am J Roentgenol. 1990;154(3):539–43.

    PubMed  CAS  Google Scholar 

  13. Oyen R, Verellen S, Drochmans A, Baert L, Marchal G, Moerman P, Baert AL. Value of MRI in the diagnosis and staging of testicular tumors. J Belge Radiol. 1993;76(2):84–9.

    PubMed  CAS  Google Scholar 

  14. Baker LL, Hajek PC, Burkhard TK, et al. MR imaging of the scrotum: pathologic conditions. Radiology. 1987;163(1): 93–8.

    PubMed  CAS  Google Scholar 

  15. Thurnher S, Hricak H, Carroll PR, Pobiel RS, Filly RA. Imaging the testis: comparison between MR imaging and US. Radiology. 1988;167(3):631–6.

    PubMed  CAS  Google Scholar 

  16. Muttarak M, Peh WC, Chaiwun B. Malignant germ cell tumours of undescended testes: imaging features with pathological correlation. Clin Radiol. 2004;59(2):198–204.

    Article  PubMed  CAS  Google Scholar 

  17. Nguyen HT, Coakley F, Hricak H. Cryptorchidism: strategies in detection. Eur Radiol. 1999;9(2):336–43.

    Article  PubMed  CAS  Google Scholar 

  18. Fritzsche PJ, Hricak H, Kogan BA, Winkler ML, Tanagho EA. Undescended testis: value of MR imaging. Radiology. 1987;164(1):169–73.

    PubMed  CAS  Google Scholar 

  19. Kier R, McCarthy S, Rosenfield AT, Rosenfield NS, Rapoport S, Weiss RM. Nonpalpable testes in young boys: evaluation with MR imaging. Radiology. 1988;169(2):429–33.

    PubMed  CAS  Google Scholar 

  20. Frush DP, Sheldon CA. Diagnostic imaging for pediatric scrotal disorders. Radiographics. 1998;18(4):969–85.

    PubMed  CAS  Google Scholar 

  21. Lam WW, Tam PK, Ai VH, Chan KL, Chan FL, Leong L. Using gadolinium-infusion MR venography to show the impalpable testis in pediatric patients. AJR Am J Roentgenol. 2001;176(5):1221–6.

    PubMed  CAS  Google Scholar 

  22. Pottern L, Goedert J. Epidemiology of testicular cancer. In: Javadpour N, editor. Principles and management of testicular cancer. New York: Thieme; 1986. pp. 107–19.

    Google Scholar 

  23. Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection? Apmis. 1998;106(1):3–11; discussion 2.

    PubMed  CAS  Google Scholar 

  24. Chaganti RS, Houldsworth J. The cytogenetic theory of the pathogenesis of human adult male germ cell tumors. Review article. Apmis. 1998;106(1):80–3; discussion 3–4.

    PubMed  CAS  Google Scholar 

  25. Oliver RT. Atrophy, hormones, genes and viruses in aetiology germ cell tumours. Cancer Surv. 1990;9(2):263–86.

    PubMed  CAS  Google Scholar 

  26. Hartmann JT, Fossa SD, Nichols CR, et al. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Natl Cancer Inst. 2001;93(22):1733–8.

    Article  PubMed  CAS  Google Scholar 

  27. Scholz M, Zehender M, Thalmann GN, Borner M, Thoni H, Studer UE. Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Ann Oncol. 2002;13(1):121–4.

    Article  PubMed  CAS  Google Scholar 

  28. Nichols CR. Mediastinal germ cell tumors. Clinical features and biologic correlates. Chest. 1991;99(2):472–9.

    Article  PubMed  CAS  Google Scholar 

  29. Williams MP, Husband JE, Heron CW. Intrathoracic manifestations of metastatic testicular seminoma: a comparison of chest radiographic and CT findings. AJR Am J Roentgenol. 1987;149(3):473–5.

    PubMed  CAS  Google Scholar 

  30. Marchevsky A, Kaneko M. Surgical pathology of the mediastinum. New York: Raven Press; 1992.

    Google Scholar 

  31. Brown LR, Aughenbaugh GL. Masses of the anterior mediastinum: CT and MR imaging. AJR Am J Roentgenol. 1991;157(6):1171–80.

    PubMed  CAS  Google Scholar 

  32. Naidich D, Webb W, Müller N, Krinsky G, Zerhouni E. computed tomography and magnetic resonance of the thorax. Lippincott Williams & Wilkins; 1998. p. 357.

    Google Scholar 

  33. Suzuki M, Takashima T, Itoh H, Choutoh S, Kawamura I, Watanabe Y. Computed tomography of mediastinal teratomas. J Comput Assist Tomogr. 1983;7(1):74–6.

    Article  PubMed  CAS  Google Scholar 

  34. Fulcher AS, Proto AV, Jolles H. Cystic teratoma of the mediastinum: demonstration of fat/fluid level. AJR Am J Roentgenol. 1990;154(2):259–60.

    PubMed  CAS  Google Scholar 

  35. Seltzer SE, Herman PG, Sagel SS. Differential diagnosis of mediastinal fluid levels visualized on computed tomography. J Comput Assist Tomogr. 1984;8(2):244–6.

    PubMed  CAS  Google Scholar 

  36. Rosado-de-Christenson ML, Templeton PA, Moran CA. From the archives of the AFIP. Mediastinal germ cell tumors: radiologic and pathologic correlation. Radiographics. 1992;12(5):1013–30.

    PubMed  CAS  Google Scholar 

  37. Lee KS, Im JG, Han CH, Han MC, Kim CW, Kim WS. Malignant primary germ cell tumors of the mediastinum: CT features. AJR Am J Roentgenol. 1989;153(5):947–51.

    PubMed  CAS  Google Scholar 

  38. Levitt RG, Husband JE, Glazer HS. CT of primary germ-cell tumors of the mediastinum. AJR Am J Roentgenol. 1984;142(1):73–8.

    PubMed  CAS  Google Scholar 

  39. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol. 1997;15(2):594–603.

    Google Scholar 

  40. Ellis JH, Bies JR, Kopecky KK, Klatte EC, Rowland RG, Donohue JP. Comparison of NMR and CT imaging in the evaluation of metastatic retroperitoneal lymphadenopathy from testicular carcinoma. J Comput Assist Tomogr. 1984;8(4):709–19.

    Article  PubMed  CAS  Google Scholar 

  41. Hogeboom WR, Hoekstra HJ, Mooyaart EL, Sleijfer DT, Freling NJ, Willemse PH, Schraffordt Koops, H. The role of magnetic resonance imaging and computed tomography in the treatment evaluation of retroperitoneal lymph-node metastases of non-seminomatous testicular tumors. Eur J Radiol. 1991;13(1):31–6.

    Article  PubMed  CAS  Google Scholar 

  42. Hogeboom WR, Hoekstra HJ, Mooyaart EL, Sleijfer DT, Schraffordt Koops H. Magnetic resonance imaging of retroperitoneal lymph node metastases of non-seminomatous germ cell tumours of the testis. Eur J Surg Oncol. 1993;19(5):429–37.

    PubMed  CAS  Google Scholar 

  43. De Santis M, Becherer A, Bokemeyer C, et al. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol. 2004;22(6):1034–9.

    Article  PubMed  Google Scholar 

  44. De Wit M, Hartmann M, Brenner W, et al. [18F]-FDG-PET in germ cell tumors following chemotherapy: results of the German multicenter trial. J. Clin Oncol. 2006 ASCO Annual Meeting Proceedings Part I. 2006;24, No 18S (June 20 Supplement): 4521.

    Google Scholar 

  45. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med. 1997;337(4):242–53.

    Article  PubMed  CAS  Google Scholar 

  46. Hartmann JT, Kanz L, Bokemeyer C. Diagnosis and treatment of patients with testicular germ cell cancer. Drugs. 1999;58(2): 257–81.

    Article  PubMed  CAS  Google Scholar 

  47. Kollmannsberger C, Nichols C, Bamberg M, et al. First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Ann Oncol. 2000;11(5):553–9.

    Article  PubMed  CAS  Google Scholar 

  48. Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. Ajnr. 1991;12(2):293–300.

    PubMed  CAS  Google Scholar 

  49. Bokemeyer C, Nowak P, Haupt A, et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol. 1997;15(4):1449–54.

    PubMed  CAS  Google Scholar 

  50. Fossa SD, Bokemeyer C, Gerl A, et al. Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer. 1999;85(4):988–97.

    Article  PubMed  CAS  Google Scholar 

  51. Schmoll HJ, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol. 2004;15(9):1377–99.

    Article  PubMed  CAS  Google Scholar 

  52. Semelka RC, Schlund JF, Molina PL, et al. Malignant liver lesions: comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. J Magn Reson Imaging. 1996;6(1):39–43.

    Article  PubMed  CAS  Google Scholar 

  53. Vassiliades VG, Foley WD, Alarcon J, et al. Hepatic metastases: CT versus MR imaging at 1.5T. Gastrointest Radiol. 1991;16(2):159–63.

    Article  PubMed  CAS  Google Scholar 

  54. Kellenberger CJ, Epelman M, Miller SF, Babyn PS. Fast STIR whole-body MR imaging in children. Radiographics. 2004;24(5):1317–30.

    Article  PubMed  Google Scholar 

  55. Walker R, Kessar P, Blanchard R, et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging. 2000;11(4):343–50.

    Article  PubMed  CAS  Google Scholar 

  56. Ladd SC, Zenge M, Antoch G, Forsting M. Whole-body MR diagnostic concepts. Rofo. 2006;178(8):763–70.

    PubMed  CAS  Google Scholar 

  57. Bellin MF, Roy C, Kinkel K, et al. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles–initial clinical experience. Radiology. 1998;207(3):799–808.

    PubMed  CAS  Google Scholar 

  58. Atri M. New technologies and directed agents for applications of cancer imaging. J Clin Oncol. 2006;24(20):3299–308.

    Article  PubMed  Google Scholar 

  59. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348(25):2491–9.

    Article  PubMed  Google Scholar 

  60. UICC manual of clinical oncology. New Jersey: John Wiley & Sons; 2004.

    Google Scholar 

  61. Husband JE, Grimer DP. Staging testicular tumours: the role of CT scanning. J R Soc Med. 1985;78 Suppl 6:25–31.

    PubMed  Google Scholar 

  62. Ehrlichman RJ, Kaufman SL, Siegelman SS, Trump DL, Walsh PC. Computerized tomography and lymphangiography in staging testis tumors. J Urol. 1981;126(2):179–81.

    PubMed  CAS  Google Scholar 

  63. Royal SA, Callen PW. CT evaluation of anomalies of the inferior vena cava and left renal vein. AJR Am J Roentgenol. 1979;132(5):759–63.

    PubMed  CAS  Google Scholar 

  64. Moul JW, Maggio MI, Hardy MR, Hartman DS. Retroaortic left renal vein in testicular cancer patient: potential staging and treatment pitfall. J Urol. 1992;147(2):454–6.

    PubMed  CAS  Google Scholar 

  65. Dixon AK, Ellis M, Sikora K. Computed tomography of testicular tumours: distribution of abdominal lymphadenopathy. Clin Radiol. 1986;37(6):519–23.

    Article  PubMed  CAS  Google Scholar 

  66. Brener BJ, Darling RC, Frederick PL, Linton RR. Major venous anomalies complicating abdominal aortic surgery. Arch Surg. 1974;108(2):159–65.

    PubMed  CAS  Google Scholar 

  67. Pick J, BJ. A. The renal vascular pedicle: an anatomical study of 430 body halves. J Urol. 1940;44:411–34.

    Google Scholar 

  68. Dubowitz DJ. Problem in diagnostic imaging. Clin Anat. 1997;10(4):279–82.

    Article  PubMed  CAS  Google Scholar 

  69. Bass JE, Redwine MD, Kramer LA, Huynh PT, Harris JH Jr. Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings. Radiographics. 2000;20(3):639–52.

    PubMed  CAS  Google Scholar 

  70. Meanock CI, Ward CS, Williams MP. A potential pitfall of pelvic computed tomography. Br J Radiol. 1988;61(727):584–5.

    Article  PubMed  CAS  Google Scholar 

  71. von Krogh J, Lien HH, Ous S, Fossa SD. Alterations in the CT image following retroperitoneal lymphadenectomy in early stage non-seminomatous testicular tumor. Acta Radiol Diagn (Stockh). 1985;26(2):187–91.

    Google Scholar 

  72. Ray B, Hajdu SI, Whitmore WF Jr. Proceedings: Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer. 1974;33(2):340–8.

    Article  PubMed  CAS  Google Scholar 

  73. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol. 1982;128(2):315–20.

    PubMed  CAS  Google Scholar 

  74. Mason MD, Featherstone T, Olliff J, Horwich A. Inguinal and iliac lymph node involvement in germ cell tumours of the testis: implications for radiological investigation and for therapy. Clin Oncol (R Coll Radiol). 1991;3(3):147–50.

    CAS  Google Scholar 

  75. Bradey N, Johnson RJ, Read G. Abdominal computed tomography in teratoma of the testis: its accuracy in stage I disease and an assessment of the distribution of retroperitoneal lymph-node metastases in other stages of the disease. Br J Radiol. 1987;60(713):487–91.

    PubMed  CAS  Google Scholar 

  76. Busch FM, Sayegh ES, Chenault OW Jr. Some uses of lymphangiography in the management of testicular tumors. J Urol. 1965;93:490–5.

    PubMed  CAS  Google Scholar 

  77. White PM, Howard GC, Best JJ, Wright AR. The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumours. Clin Radiol. 1997;52(2):124–9.

    Article  PubMed  CAS  Google Scholar 

  78. Page JE, Prendergast CM, King DM. Retroperitoneal haematoma following orchidectomy: implications for staging computed tomography. Br J Radiol. 1990;63(750):490–2.

    PubMed  CAS  Google Scholar 

  79. Kullmann G, Lien HH. Intraabdominal hematoma following orchiectomy: a potential pitfall in using CT for staging of testicular cancer. Radiology. 1987;163(1):129–30.

    PubMed  CAS  Google Scholar 

  80. Tran T, Grech P, Crofton ME. Computed tomographic staging of testicular tumours: an unexpected source of error. Br J Radiol. 1989;62(742):942–4.

    PubMed  CAS  Google Scholar 

  81. Leibovitch L, Foster RS, Kopecky KK, Donohue JP. Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J Urol. 1995;154(5):1759–63.

    Article  PubMed  CAS  Google Scholar 

  82. Lien HH, Stenwig AE, Ous S, Fossa SD. Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumor. Acta Radiol Diagn (Stockh). 1986;27(2):199–203.

    CAS  Google Scholar 

  83. Prokop M, Galanski M. Spiral and multisclice computed tomography of the body. Thieme Medical Publishers; 2003.

    Google Scholar 

  84. Forsberg L, Dale L, Hoiem L, et al. Computed tomography in early stages of testicular carcinoma. Size of normal retroperitoneal lymph nodes and lymph nodes in patients with metastases in stage II A. A SWENOTECA study: Swedish-Norwegian Testicular Cancer Project. Acta Radiol Diagn (Stockh). 1986;27(5):569–74.

    CAS  Google Scholar 

  85. World Health Organization. Handbook for reporting results of cancer treatment. 1979. WHO Offset Publication No 48.

    Google Scholar 

  86. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–16.

    Article  PubMed  CAS  Google Scholar 

  87. Jaffe CC. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol. 2006;24(20):3245–51.

    Article  PubMed  Google Scholar 

  88. Lien HH, Lindskold L, Stenwig AE, Ous S, Fossa SD. Shape of retroperitoneal lymph nodes at computed tomography does not correlate to metastatic disease in early stage non-seminomatous testicular tumors. Acta Radiol. 1987;28(3):271–3.

    Article  PubMed  CAS  Google Scholar 

  89. Fernandez EB, Moul JW, Foley JP, Colon E, McLeod DG. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. Urology. 1994;44(4):548–52.

    Article  PubMed  CAS  Google Scholar 

  90. Donohue JP, Thornhill JA, Foster RS, Bihrle R, Rowland RG, Einhorn LH. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989). J Urol. 1995;153(1):85–9.

    Article  PubMed  CAS  Google Scholar 

  91. Stephenson AJ, Bosl GJ, Motzer RJ, et al. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. J Clin Oncol. 2005;23(12):2781–8.

    Article  PubMed  Google Scholar 

  92. Gatti JM, Stephenson RA. Staging of testis cancer. Combining serum markers, histologic parameters, and radiographic imaging. Urol Clin North Am. 1998;25(3):397–403.

    Article  PubMed  CAS  Google Scholar 

  93. Hilton S, Herr HW, Teitcher JB, Begg CB, Castellino RA. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol. 1997;169(2):521–5.

    PubMed  CAS  Google Scholar 

  94. Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology. 1991;180(2):319–22.

    PubMed  CAS  Google Scholar 

  95. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965–1989. Br J Urol. 1993;71(3):326–35.

    PubMed  CAS  Google Scholar 

  96. Stomper PC, Fung CY, Socinski MA, Jochelson MS, Garnick MB, Richie JP. Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria. AJR Am J Roentgenol. 1987;149(6):1187–90.

    PubMed  CAS  Google Scholar 

  97. Moul JW. Proper staging techniques in testicular cancer patients. Tech Urol. 1995;1(3):126–32.

    PubMed  CAS  Google Scholar 

  98. MacVicar D. Staging of testicular germ cell tumours. Clin Radiol. 1993;47(3):149–58.

    Article  PubMed  CAS  Google Scholar 

  99. Lien HH, Lindskold L, Fossa SD, Aass N. Computed tomography and conventional radiography in intrathoracic metastases from non-seminomatous testicular tumor. Acta Radiol. 1988;29(5):547–9.

    PubMed  CAS  Google Scholar 

  100. See WA, Hoxie L. Chest staging in testis cancer patients: imaging modality selection based upon risk assessment as determined by abdominal computerized tomography scan results. J Urol. 1993;150(3):874–8.

    PubMed  CAS  Google Scholar 

  101. White PM, Adamson DJ, Howard GC, Wright AR. Imaging of the thorax in the management of germ cell testicular tumours. Clin Radiol. 1999;54(4):207–11.

    Article  PubMed  CAS  Google Scholar 

  102. Cagini L, Nicholson AG, Horwich A, Goldstraw P, Pastorino U. Thoracic metastasectomy for germ cell tumours: long term survival and prognostic factors. Ann Oncol. 1998;9(11):1185–91.

    Article  PubMed  CAS  Google Scholar 

  103. Meyer CA, Conces DJ. Imaging of intrathoracic metastases of nonseminomatous germ cell tumors. Chest Surg Clin N Am. 2002;12(4):717–38.

    PubMed  Google Scholar 

  104. Wood A, Robson N, Tung K, Mead G. Patterns of supradiaphragmatic metastases in testicular germ cell tumours. Clin Radiol. 1996;51(4):273–6.

    Article  PubMed  CAS  Google Scholar 

  105. Choi YW, McAdams HP, Jeon SC, Seo HS, Hahm CK. The “High-Riding” superior pericardial recess: CT findings. AJR Am J Roentgenol. 2000;175(4):1025–8.

    PubMed  CAS  Google Scholar 

  106. Budoff MJ, Lu B, Mao S, et al. Evaluation of fluid collection in the pericardial sinuses and recesses: noncontrast-enhanced electron beam tomography. Invest Radiol. 2000;35(6):359–65.

    Article  PubMed  CAS  Google Scholar 

  107. Gollub MJ, Castellino RA. The cisterna chyli: a potential mimic of retrocrural lymphadenopathy on CT scans. Radiology. 1996;199(2):477–80.

    PubMed  CAS  Google Scholar 

  108. Webb W, Müller N, Naidich D. High-resolution CT of the lung. 3rd ed. Lippincott Williams & Wilkins; 2000.

    Google Scholar 

  109. Donohue JP, Rowland RG, Kopecky K, et al. Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol. 1987;137(6): 1176–9.

    PubMed  CAS  Google Scholar 

  110. Steyerberg EW, Gerl A, Fossa SD, et al. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. J Clin Oncol. 1998;16(1):269–74.

    PubMed  CAS  Google Scholar 

  111. Toner GC, Panicek DM, Heelan RT, et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol. 1990;8(10): 1683–94.

    PubMed  CAS  Google Scholar 

  112. Fizazi K, Tjulandin S, Salvioni R, et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy–results from an international study group. J Clin Oncol. 2001;19(10):2647–57.

    PubMed  CAS  Google Scholar 

  113. Loehrer PJ Sr, Hui S, Clark S, et al. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation. J Urol. 1986;135(6):1183–9.

    Google Scholar 

  114. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 2000;20(5):1245–59.

    PubMed  CAS  Google Scholar 

  115. White DA, Stover DE. Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids. Chest. 1984;86(5):723–8.

    Article  PubMed  CAS  Google Scholar 

  116. Glasier CM, Siegel MJ. Multiple pulmonary nodules: unusual manifestation of bleomycin toxicity. AJR Am J Roentgenol. 1981;137(1):155–6.

    PubMed  CAS  Google Scholar 

  117. Lien HH, Brodahl U, Telhaug R, Holthe H, Fossa SD. Pulmonary changes at computed tomography in patients with testicular carcinoma treated with cis-platinum, vinblastine and bleomycin. Acta Radiol Diagn (Stockh). 1985;26(5):507–10.

    CAS  Google Scholar 

  118. Tait DM, Goldstraw P, Husband JE. Thymic rebound in an adult following chemotherapy for testicular cancer. Eur J Surg Oncol. 1986;12(4):385–7.

    PubMed  CAS  Google Scholar 

  119. Carmosino L, DiBenedetto A, Feffer S. Thymic hyperplasia following successful chemotherapy. A report of two cases and review of the literature. Cancer. 1985;56(7):1526–8.

    Article  PubMed  CAS  Google Scholar 

  120. Due W, Dieckmann KP, Stein H. Thymic hyperplasia following chemotherapy of a testicular germ cell tumor. Immunohistological evidence for a simple rebound phenomenon. Cancer. 1989;63(3):446–9.

    Article  PubMed  CAS  Google Scholar 

  121. Kissin CM, Husband JE, Nicholas D, Eversman W. Benign thymic enlargement in adults after chemotherapy: CT demonstration. Radiology. 1987;163(1):67–70.

    PubMed  CAS  Google Scholar 

  122. Murphy BR, Conces DJ Jr, Nichols CR. Thymic hyperplasia after chemotherapy: two case reports and a literature review. Indiana Med. 1991;84(9):624–7.

    PubMed  CAS  Google Scholar 

  123. UNSCEAR: United Nations Scientific Committee on the Effects of Atomic Radiation. 2000 Report to the General Assembly, Annex D: medical radiation exposures. New York, United Nations, 2000.

    Google Scholar 

  124. Shrimpton PC, Edyvean S. CT scanner dosimetry. Br J Radiol. 1998;71(841):1–3.

    PubMed  CAS  Google Scholar 

  125. IAEA Annual Report: Nuclear Safety Review for the Year 2005.

    Google Scholar 

  126. Mayo JR, Aldrich J, Muller NL. Radiation exposure at chest CT: a statement of the Fleischner Society. Radiology. 2003;228(1): 15–21.

    Article  PubMed  Google Scholar 

  127. ICRP. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. Publication 60. 1991.

    Google Scholar 

  128. BEIR V. Health effects of exposure to low-levels of ionizing radiation. Committee on the biological effects of ionizing radiations. Washington DC: National Academic Press; 1990.

    Google Scholar 

  129. Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology. 2004;232(3): 735–8.

    Article  PubMed  Google Scholar 

  130. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176(2):289–96.

    PubMed  CAS  Google Scholar 

  131. Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res. 2000;154(2): 178–86.

    Article  PubMed  CAS  Google Scholar 

  132. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950–1990. Radiat Res. 1996;146(1):1–27.

    Article  PubMed  CAS  Google Scholar 

  133. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950–1997. Radiat Res. 2003;160(4):381–407.

    Article  PubMed  CAS  Google Scholar 

  134. Kalra MK, Maher MM, Toth TL, et al. Strategies for CT radiation dose optimization. Radiology. 2004;230(3):619–28.

    Article  PubMed  Google Scholar 

  135. Ravenel JG, Scalzetti EM, Huda W, Garrisi W. Radiation exposure and image quality in chest CT examinations. AJR Am J Roentgenol. 2001;177(2):279–84.

    PubMed  CAS  Google Scholar 

  136. Haaga JR. Radiation dose management: weighing risk versus benefit. AJR Am J Roentgenol. 2001;177(2):289–91.

    PubMed  CAS  Google Scholar 

  137. Prasad SR, Wittram C, Shepard JA, McLoud T, Rhea J. Standard-dose and 50%-reduced-dose chest CT: comparing the effect on image quality. AJR Am J Roentgenol. 2002;179(2):461–5.

    PubMed  Google Scholar 

  138. Slovis TL. CT and computed radiography: the pictures are great, but is the radiation dose greater than required? AJR Am J Roentgenol. 2002;179(1):39–41.

    PubMed  Google Scholar 

  139. Zhu X, Yu J, Huang Z. Low-dose chest CT: optimizing radiation protection for patients. AJR Am J Roentgenol. 2004;183(3): 809–16.

    PubMed  Google Scholar 

  140. Nickoloff EL, Alderson PO. Radiation exposures to patients from CT: reality, public perception, and policy. AJR Am J Roentgenol. 2001;177(2):285–7.

    PubMed  CAS  Google Scholar 

  141. Fitzgerald R, Twiss D, Mehra R, Evans M, Qaiyum M, Collins M. Low-dose computed tomography surveillance of patients with testicular tumours. Clin Oncol (R Coll Radiol). 2004; 16(2):158.

    CAS  Google Scholar 

  142. Wright AR, Collie DA, Williams JR, Hashemi-Malayeri B, Stevenson AJ, Turnbull CM. Pulmonary nodules: effect on detection of spiral CT pitch. Radiology. 1996;199(3):837–41.

    PubMed  CAS  Google Scholar 

  143. Rustin GJ, Mead GM, Stenning SP, et al. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197—the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol. 2007;25:1310–5.

    Article  PubMed  Google Scholar 

  144. Fernandez EB, Colon E, McLeod DG, Moul JW. Efficacy of radiographic chest imaging in patients with testicular cancer. Urology. 1994;44(2):243–8; discussion 8–9.

    Article  PubMed  CAS  Google Scholar 

  145. Harvey ML, Geldart TR, Duell R, Mead GM, Tung K. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer–a necessary risk? Ann Oncol. 2002;13(2):237–42.

    Article  PubMed  CAS  Google Scholar 

  146. Segal R, Lukka H, Klotz LH, Eady A, Bestic N, Johnston M. Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline. Can J Urol. 2001;8(1):1184–92.

    PubMed  CAS  Google Scholar 

  147. Sharir S, Foster RS, Donohue JP, Jewett MA. What is the appropriate follow-up after treatment? Semin Urol Oncol. 1996;14(1):45–53.

    PubMed  CAS  Google Scholar 

  148. Gels ME, Hoekstra HJ, Sleijfer DT, et al. Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience. J Clin Oncol. 1995;13(5): 1188–94.

    PubMed  CAS  Google Scholar 

  149. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis. 1986;133(2):321–40.

    PubMed  CAS  Google Scholar 

  150. Aronchick JM, Gefter WB. Drug-induced pulmonary disorders. Semin Roentgenol. 1995;30(1):18–34.

    Article  PubMed  CAS  Google Scholar 

  151. Lee-Chiong T. Drug-induced pulmonary disorders. In: Sperber M, editor. Diffuse lung disorders: a comprehensive clinical-radiological overview. Springer; 1999. pp. 403–36.

    Google Scholar 

  152. Balikian JP, Jochelson MS, Bauer KA, et al. Pulmonary complications of chemotherapy regimens containing bleomycin. AJR Am J Roentgenol. 1982;139(3):455–61.

    PubMed  CAS  Google Scholar 

  153. Webb W, Higgins C. Thoracic imaging: pulmonary and cardiovascular radiology. Lippincott Williams & Wilkins; 2004. pp. 463–74.

    Google Scholar 

  154. O’Sullivan JM, Huddart RA, Norman AR, Nicholls J, Dearnaley DP, Horwich A. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol. 2003;14(1):91–6.

    Article  PubMed  CAS  Google Scholar 

  155. Bellamy EA, Husband JE, Blaquiere RM, Law MR. Bleomycin-related lung damage: CT evidence. Radiology. 1985;156(1): 155–8.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 3rd Medical Department – Center for Oncology and Hematology, Kaiser Franz Josef – Spital der Stadt Wien and Ludwig Boltzmann-Institute for Applied Cancer Research Vienna (LBI-ACR VIEnna), Kundratstrasse 3, A-1100 Vienna, Austria

    M. De Santis & M. Bachner

  2. Department of Radiology, Kaiser Franz Josef - Spital der Stadt Wien, Kundratstrasse 3, A-1100 Vienna, Austria

    G. Strau

Authors
  1. M. De Santis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Strau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Bachner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Academic Medical Center, Amsterdam, The Netherlands

    Jean J.M.C.H. de la Rosette  & Hessel Wijkstra  & 

  2. Department of Urology, The George Washington University, Washington, USA

    Michael J. Manyak

  3. Department of Radiology, Massachusetts General Hospital, Boston, DC, USA

    Mukesh G. Harisinghani

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Santis, M.D., Strau, G., Bachner, M. (2009). Cross-Sectional Imaging Techniques: The Use of Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) in the Management of Germ Cell Tumors. In: de la Rosette, J.J., Manyak, M.J., Harisinghani, M.G., Wijkstra, H. (eds) Imaging in Oncological Urology. Springer, London. https://doi.org/10.1007/978-1-84628-759-6_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-759-6_27

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-514-1

  • Online ISBN: 978-1-84628-759-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation